Global Testosterone Blocker Supply, Demand and Key Producers, 2023-2029

February 2023 | 106 pages | ID: GB127BF8FC4FEN
GlobalInfoResearch

Abstracts

This report studies the global Testosterone Blocker demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Testosterone Blocker, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Testosterone Blocker that contribute to its increasing demand across many markets.

The global Testosterone Blocker market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Testosterone Blocker total market, 2018-2029, (USD Million)

Global Testosterone Blocker total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Testosterone Blocker total market, key domestic companies and share, (USD Million)

Global Testosterone Blocker revenue by player and market share 2018-2023, (USD Million)

Global Testosterone Blocker total market by Type, CAGR, 2018-2029, (USD Million)

Global Testosterone Blocker total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Testosterone Blocker market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Orion Corporation, Hengrui and Bayer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Testosterone Blocker market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Testosterone Blocker Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Testosterone Blocker Market, Segmentation by Type

• Steroidal Testosterone Blocker
• Nonsteroidal Testosterone Blocker

Global Testosterone Blocker Market, Segmentation by Application

• Prostate Cancer
• Benign Prostatic Hyperplasia
• Polycystic Ovary Syndrome (POCS)
• Others

Companies Profiled:

• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Merck
• Sanofi
• Orion Corporation
• Hengrui
• Bayer
• Schering-Plough
• Hinova Pharma
• Jiangsu Hengrui Pharmaceuticals

Key Questions Answered

1. How big is the global Testosterone Blocker market?

2. What is the demand of the global Testosterone Blocker market?

3. What is the year over year growth of the global Testosterone Blocker market?

4. What is the total value of the global Testosterone Blocker market?

5. Who are the major players in the global Testosterone Blocker market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Testosterone Blocker Introduction
1.2 World Testosterone Blocker Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Testosterone Blocker Total Market by Region (by Headquarter Location)
  1.3.1 World Testosterone Blocker Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Testosterone Blocker Market Size (2018-2029)
  1.3.3 China Testosterone Blocker Market Size (2018-2029)
  1.3.4 Europe Testosterone Blocker Market Size (2018-2029)
  1.3.5 Japan Testosterone Blocker Market Size (2018-2029)
  1.3.6 South Korea Testosterone Blocker Market Size (2018-2029)
  1.3.7 ASEAN Testosterone Blocker Market Size (2018-2029)
  1.3.8 India Testosterone Blocker Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Testosterone Blocker Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Testosterone Blocker Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Testosterone Blocker Consumption Value (2018-2029)
2.2 World Testosterone Blocker Consumption Value by Region
  2.2.1 World Testosterone Blocker Consumption Value by Region (2018-2023)
  2.2.2 World Testosterone Blocker Consumption Value Forecast by Region (2024-2029)
2.3 United States Testosterone Blocker Consumption Value (2018-2029)
2.4 China Testosterone Blocker Consumption Value (2018-2029)
2.5 Europe Testosterone Blocker Consumption Value (2018-2029)
2.6 Japan Testosterone Blocker Consumption Value (2018-2029)
2.7 South Korea Testosterone Blocker Consumption Value (2018-2029)
2.8 ASEAN Testosterone Blocker Consumption Value (2018-2029)
2.9 India Testosterone Blocker Consumption Value (2018-2029)

3 WORLD TESTOSTERONE BLOCKER COMPANIES COMPETITIVE ANALYSIS

3.1 World Testosterone Blocker Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Testosterone Blocker Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Testosterone Blocker in 2022
  3.2.3 Global Concentration Ratios (CR8) for Testosterone Blocker in 2022
3.3 Testosterone Blocker Company Evaluation Quadrant
3.4 Testosterone Blocker Market: Overall Company Footprint Analysis
  3.4.1 Testosterone Blocker Market: Region Footprint
  3.4.2 Testosterone Blocker Market: Company Product Type Footprint
  3.4.3 Testosterone Blocker Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Testosterone Blocker Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Testosterone Blocker Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Testosterone Blocker Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Testosterone Blocker Consumption Value Comparison
  4.2.1 United States VS China: Testosterone Blocker Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Testosterone Blocker Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Testosterone Blocker Companies and Market Share, 2018-2023
  4.3.1 United States Based Testosterone Blocker Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Testosterone Blocker Revenue, (2018-2023)
4.4 China Based Companies Testosterone Blocker Revenue and Market Share, 2018-2023
  4.4.1 China Based Testosterone Blocker Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Testosterone Blocker Revenue, (2018-2023)
4.5 Rest of World Based Testosterone Blocker Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Testosterone Blocker Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Testosterone Blocker Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Testosterone Blocker Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Steroidal Testosterone Blocker
  5.2.2 Nonsteroidal Testosterone Blocker
5.3 Market Segment by Type
  5.3.1 World Testosterone Blocker Market Size by Type (2018-2023)
  5.3.2 World Testosterone Blocker Market Size by Type (2024-2029)
  5.3.3 World Testosterone Blocker Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Testosterone Blocker Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Prostate Cancer
  6.2.2 Benign Prostatic Hyperplasia
  6.2.3 Polycystic Ovary Syndrome (POCS)
  6.2.4 Others
  6.2.5 Others
6.3 Market Segment by Application
  6.3.1 World Testosterone Blocker Market Size by Application (2018-2023)
  6.3.2 World Testosterone Blocker Market Size by Application (2024-2029)
  6.3.3 World Testosterone Blocker Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Pfizer
  7.1.1 Pfizer Details
  7.1.2 Pfizer Major Business
  7.1.3 Pfizer Testosterone Blocker Product and Services
  7.1.4 Pfizer Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Pfizer Recent Developments/Updates
  7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Details
  7.2.2 Johnson & Johnson Major Business
  7.2.3 Johnson & Johnson Testosterone Blocker Product and Services
  7.2.4 Johnson & Johnson Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Johnson & Johnson Recent Developments/Updates
  7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.3 AstraZeneca
  7.3.1 AstraZeneca Details
  7.3.2 AstraZeneca Major Business
  7.3.3 AstraZeneca Testosterone Blocker Product and Services
  7.3.4 AstraZeneca Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 AstraZeneca Recent Developments/Updates
  7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 Astellas
  7.4.1 Astellas Details
  7.4.2 Astellas Major Business
  7.4.3 Astellas Testosterone Blocker Product and Services
  7.4.4 Astellas Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Astellas Recent Developments/Updates
  7.4.6 Astellas Competitive Strengths & Weaknesses
7.5 Merck
  7.5.1 Merck Details
  7.5.2 Merck Major Business
  7.5.3 Merck Testosterone Blocker Product and Services
  7.5.4 Merck Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Merck Recent Developments/Updates
  7.5.6 Merck Competitive Strengths & Weaknesses
7.6 Sanofi
  7.6.1 Sanofi Details
  7.6.2 Sanofi Major Business
  7.6.3 Sanofi Testosterone Blocker Product and Services
  7.6.4 Sanofi Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Sanofi Recent Developments/Updates
  7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Orion Corporation
  7.7.1 Orion Corporation Details
  7.7.2 Orion Corporation Major Business
  7.7.3 Orion Corporation Testosterone Blocker Product and Services
  7.7.4 Orion Corporation Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Orion Corporation Recent Developments/Updates
  7.7.6 Orion Corporation Competitive Strengths & Weaknesses
7.8 Hengrui
  7.8.1 Hengrui Details
  7.8.2 Hengrui Major Business
  7.8.3 Hengrui Testosterone Blocker Product and Services
  7.8.4 Hengrui Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Hengrui Recent Developments/Updates
  7.8.6 Hengrui Competitive Strengths & Weaknesses
7.9 Bayer
  7.9.1 Bayer Details
  7.9.2 Bayer Major Business
  7.9.3 Bayer Testosterone Blocker Product and Services
  7.9.4 Bayer Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Bayer Recent Developments/Updates
  7.9.6 Bayer Competitive Strengths & Weaknesses
7.10 Schering-Plough
  7.10.1 Schering-Plough Details
  7.10.2 Schering-Plough Major Business
  7.10.3 Schering-Plough Testosterone Blocker Product and Services
  7.10.4 Schering-Plough Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Schering-Plough Recent Developments/Updates
  7.10.6 Schering-Plough Competitive Strengths & Weaknesses
7.11 Hinova Pharma
  7.11.1 Hinova Pharma Details
  7.11.2 Hinova Pharma Major Business
  7.11.3 Hinova Pharma Testosterone Blocker Product and Services
  7.11.4 Hinova Pharma Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Hinova Pharma Recent Developments/Updates
  7.11.6 Hinova Pharma Competitive Strengths & Weaknesses
7.12 Jiangsu Hengrui Pharmaceuticals
  7.12.1 Jiangsu Hengrui Pharmaceuticals Details
  7.12.2 Jiangsu Hengrui Pharmaceuticals Major Business
  7.12.3 Jiangsu Hengrui Pharmaceuticals Testosterone Blocker Product and Services
  7.12.4 Jiangsu Hengrui Pharmaceuticals Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
  7.12.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Testosterone Blocker Industry Chain
8.2 Testosterone Blocker Upstream Analysis
8.3 Testosterone Blocker Midstream Analysis
8.4 Testosterone Blocker Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Testosterone Blocker Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Testosterone Blocker Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Testosterone Blocker Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Testosterone Blocker Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Testosterone Blocker Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Testosterone Blocker Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Testosterone Blocker Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Testosterone Blocker Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Testosterone Blocker Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Testosterone Blocker Players in 2022
Table 12. World Testosterone Blocker Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Testosterone Blocker Company Evaluation Quadrant
Table 14. Head Office of Key Testosterone Blocker Player
Table 15. Testosterone Blocker Market: Company Product Type Footprint
Table 16. Testosterone Blocker Market: Company Product Application Footprint
Table 17. Testosterone Blocker Mergers & Acquisitions Activity
Table 18. United States VS China Testosterone Blocker Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Testosterone Blocker Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Testosterone Blocker Companies, Headquarters (States, Country)
Table 21. United States Based Companies Testosterone Blocker Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Testosterone Blocker Revenue Market Share (2018-2023)
Table 23. China Based Testosterone Blocker Companies, Headquarters (Province, Country)
Table 24. China Based Companies Testosterone Blocker Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Testosterone Blocker Revenue Market Share (2018-2023)
Table 26. Rest of World Based Testosterone Blocker Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Testosterone Blocker Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Testosterone Blocker Revenue Market Share (2018-2023)
Table 29. World Testosterone Blocker Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Testosterone Blocker Market Size by Type (2018-2023) & (USD Million)
Table 31. World Testosterone Blocker Market Size by Type (2024-2029) & (USD Million)
Table 32. World Testosterone Blocker Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Testosterone Blocker Market Size by Application (2018-2023) & (USD Million)
Table 34. World Testosterone Blocker Market Size by Application (2024-2029) & (USD Million)
Table 35. Pfizer Basic Information, Area Served and Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Testosterone Blocker Product and Services
Table 38. Pfizer Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Pfizer Recent Developments/Updates
Table 40. Pfizer Competitive Strengths & Weaknesses
Table 41. Johnson & Johnson Basic Information, Area Served and Competitors
Table 42. Johnson & Johnson Major Business
Table 43. Johnson & Johnson Testosterone Blocker Product and Services
Table 44. Johnson & Johnson Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Johnson & Johnson Recent Developments/Updates
Table 46. Johnson & Johnson Competitive Strengths & Weaknesses
Table 47. AstraZeneca Basic Information, Area Served and Competitors
Table 48. AstraZeneca Major Business
Table 49. AstraZeneca Testosterone Blocker Product and Services
Table 50. AstraZeneca Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AstraZeneca Recent Developments/Updates
Table 52. AstraZeneca Competitive Strengths & Weaknesses
Table 53. Astellas Basic Information, Area Served and Competitors
Table 54. Astellas Major Business
Table 55. Astellas Testosterone Blocker Product and Services
Table 56. Astellas Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Astellas Recent Developments/Updates
Table 58. Astellas Competitive Strengths & Weaknesses
Table 59. Merck Basic Information, Area Served and Competitors
Table 60. Merck Major Business
Table 61. Merck Testosterone Blocker Product and Services
Table 62. Merck Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck Recent Developments/Updates
Table 64. Merck Competitive Strengths & Weaknesses
Table 65. Sanofi Basic Information, Area Served and Competitors
Table 66. Sanofi Major Business
Table 67. Sanofi Testosterone Blocker Product and Services
Table 68. Sanofi Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Sanofi Recent Developments/Updates
Table 70. Sanofi Competitive Strengths & Weaknesses
Table 71. Orion Corporation Basic Information, Area Served and Competitors
Table 72. Orion Corporation Major Business
Table 73. Orion Corporation Testosterone Blocker Product and Services
Table 74. Orion Corporation Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Orion Corporation Recent Developments/Updates
Table 76. Orion Corporation Competitive Strengths & Weaknesses
Table 77. Hengrui Basic Information, Area Served and Competitors
Table 78. Hengrui Major Business
Table 79. Hengrui Testosterone Blocker Product and Services
Table 80. Hengrui Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Hengrui Recent Developments/Updates
Table 82. Hengrui Competitive Strengths & Weaknesses
Table 83. Bayer Basic Information, Area Served and Competitors
Table 84. Bayer Major Business
Table 85. Bayer Testosterone Blocker Product and Services
Table 86. Bayer Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Bayer Recent Developments/Updates
Table 88. Bayer Competitive Strengths & Weaknesses
Table 89. Schering-Plough Basic Information, Area Served and Competitors
Table 90. Schering-Plough Major Business
Table 91. Schering-Plough Testosterone Blocker Product and Services
Table 92. Schering-Plough Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Schering-Plough Recent Developments/Updates
Table 94. Schering-Plough Competitive Strengths & Weaknesses
Table 95. Hinova Pharma Basic Information, Area Served and Competitors
Table 96. Hinova Pharma Major Business
Table 97. Hinova Pharma Testosterone Blocker Product and Services
Table 98. Hinova Pharma Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Hinova Pharma Recent Developments/Updates
Table 100. Jiangsu Hengrui Pharmaceuticals Basic Information, Area Served and Competitors
Table 101. Jiangsu Hengrui Pharmaceuticals Major Business
Table 102. Jiangsu Hengrui Pharmaceuticals Testosterone Blocker Product and Services
Table 103. Jiangsu Hengrui Pharmaceuticals Testosterone Blocker Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Testosterone Blocker Upstream (Raw Materials)
Table 105. Testosterone Blocker Typical Customers
List of Figure
Figure 1. Testosterone Blocker Picture
Figure 2. World Testosterone Blocker Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Testosterone Blocker Total Market Size (2018-2029) & (USD Million)
Figure 4. World Testosterone Blocker Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Testosterone Blocker Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Testosterone Blocker Revenue (2018-2029) & (USD Million)
Figure 13. Testosterone Blocker Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 16. World Testosterone Blocker Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 18. China Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 23. India Testosterone Blocker Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Testosterone Blocker by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Testosterone Blocker Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Testosterone Blocker Markets in 2022
Figure 27. United States VS China: Testosterone Blocker Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Testosterone Blocker Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Testosterone Blocker Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Testosterone Blocker Market Size Market Share by Type in 2022
Figure 31. Steroidal Testosterone Blocker
Figure 32. Nonsteroidal Testosterone Blocker
Figure 33. World Testosterone Blocker Market Size Market Share by Type (2018-2029)
Figure 34. World Testosterone Blocker Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Testosterone Blocker Market Size Market Share by Application in 2022
Figure 36. Prostate Cancer
Figure 37. Benign Prostatic Hyperplasia
Figure 38. Polycystic Ovary Syndrome (POCS)
Figure 39. Others
Figure 40. Testosterone Blocker Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source